title: Virulence attenuation during an influenza A/H5N1 pandemic.
abstract: More than 15 years after the first human cases of influenza A/H5N1 in Hong Kong, the world remains at risk for an H5N1 pandemic. Preparedness activities have focused on antiviral stockpiling and distribution, development of a human H5N1 vaccine, operationalizing screening and social distancing policies, and other non-pharmaceutical interventions. The planning of these interventions has been done in an attempt to lessen the cumulative mortality resulting from a hypothetical H5N1 pandemic. In this theoretical study, we consider the natural limitations on an H5N1 pandemic's mortality imposed by the virus' epidemiological-evolutionary constraints. Evolutionary theory dictates that pathogens should evolve to be relatively benign, depending on the magnitude of the correlation between a pathogen's virulence and its transmissibility. Because the case fatality of H5N1 infections in humans is currently 60 per cent, it is doubtful that the current viruses are close to their evolutionary optimum for transmission among humans. To describe the dynamics of virulence evolution during an H5N1 pandemic, we build a mathematical model based on the patterns of clinical progression in past H5N1 cases. Using both a deterministic model and a stochastic individual-based simulation, we describe (i) the drivers of evolutionary dynamics during an H5N1 pandemic, (ii) the range of case fatalities for which H5N1 viruses can successfully cause outbreaks in humans, and (iii) the effects of different kinds of social distancing on virulence evolution. We discuss two main epidemiological-evolutionary features of this system (i) the delaying or slowing of an epidemic which results in a majority of hosts experiencing an attenuated virulence phenotype and (ii) the strong evolutionary pressure for lower virulence experienced by the virus during a period of intense social distancing.
authors: Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam. mboni@oucru.org
authors: Maciej F
authors: MF
authors: Boni
authors: Tran Dang
authors: TD
authors: Nguyen
authors: Menno D
authors: MD
authors: de Jong
authors: H Rogier
authors: HR
authors: van Doorn
mesh_terms: D003198:Computer Simulation; D019143:Evolution, Molecular; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000235:genetics* / Q000472:pathogenicity*; D007251:Influenza, Human / Q000453:epidemiology* / Q000821:virology*; D008957:Models, Genetic; D058873:Pandemics / Q000517:prevention & control*; D014774:Virulence
references: PLoS Pathog. 2010 Oct 07;6(10):e1001139
references: 20949022
references: Trends Microbiol. 2008 Apr;16(4):149-57
references: 18375125
references: Science. 2005 Aug 12;309(5737):1083-7
references: 16079251
references: J Infect Dis. 2012 Jan 1;205(1):35-43
references: 22131338
references: Emerg Infect Dis. 2008 Jun;14(6):875-80
references: 18507896
references: Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2211-3
references: 22308474
references: Science. 2006 Apr 21;312(5772):389-91
references: 16627735
references: Q Rev Biol. 1996 Mar;71(1):37-78
references: 8919665
references: Evolution. 2009 Apr;63(4):826-38
references: 19154387
references: Lancet Infect Dis. 2009 May;9(5):301-11
references: 19393960
references: Proc Biol Sci. 2006 Dec 7;273(1604):2945-53
references: 17015361
references: Vaccine. 2012 Jan 5;30(2):329-35
references: 22080174
references: Proc R Soc Lond B Biol Sci. 1983 Oct 22;219(1216):281-313
references: 6139816
references: PLoS One. 2012;7(2):e30333
references: 22393352
references: Am Nat. 2004 Apr;163(4):E40-63
references: 15122509
references: Clin Infect Dis. 2011 Aug 1;53(3):277-9
references: 21677258
references: Clin Microbiol Rev. 2007 Apr;20(2):243-67
references: 17428885
references: Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6872-7
references: 19332788
references: N Engl J Med. 2006 Nov 23;355(21):2179-85
references: 17124015
references: Emerg Infect Dis. 2011 Oct;17(10):1824-30
references: 22000351
references: J Infect Dis. 2007 Aug 15;196(4):522-7
references: 17624836
references: Influenza Other Respir Viruses. 2013 Jan;7(1):55-65
references: 22405557
references: Int J Biochem Cell Biol. 2008;40(12):2671-4
references: 18588994
references: J Gen Virol. 2011 Jun;92(Pt 6):1435-1444
references: 21367983
references: PLoS One. 2012;7(8):e43115
references: 22952637
references: J Infect Dis. 2010 Oct 15;202(8):1154-60
references: 20831384
references: Proc Natl Acad Sci U S A. 2012 May 22;109(21):E1332; author reply E1333
references: 22550184
references: Vaccine. 2012 Jun 22;30(30):4419-34
references: 22537992
references: J R Soc Interface. 2007 Jun 22;4(14):505-21
references: 17251132
references: Nature. 2006 Mar 23;440(7083):435-6
references: 16554799
references: J Clin Invest. 1998 Feb 1;101(3):643-9
references: 9449698
references: Science. 2005 Nov 18;310(5751):1112-3
references: 16293738
references: Emerg Infect Dis. 2006 Jan;12(1):15-22
references: 16494711
references: N Engl J Med. 2006 Nov 23;355(21):2186-94
references: 17124016
references: N Engl J Med. 2004 Mar 18;350(12):1179-88
references: 14985470
references: Emerg Infect Dis. 2006 Jun;12(6):881-6
references: 16707041
references: Proc Biol Sci. 2006 Jun 7;273(1592):1307-16
references: 16777717
references: Emerg Infect Dis. 2005 Feb;11(2):201-9
references: 15752436
references: Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4620-4
references: 15070767
references: Proc Natl Acad Sci U S A. 2004 May 25;101(21):8156-61
references: 15148370
references: Nature. 2012 May 02;486(7403):420-8
references: 22722205
references: N Engl J Med. 2008 Jan 17;358(3):261-73
references: 18199865
references: Science. 2012 Jun 22;336(6088):1534-41
references: 22723413
references: J Infect Dis. 2009 Oct 15;200(8):1232-41
references: 19743921
references: Nat Med. 2006 Oct;12(10):1203-7
references: 16964257
references: Nature. 2003 Dec 11;426(6967):658-61
references: 14668863
references: Virus Res. 1993 Aug;29(2):155-65
references: 8212857
references: Nature. 2004 Jul 8;430(6996):209-13
references: 15241415
references: Nature. 1970 Aug 1;227(5257):520-1
references: 5428476
references: PLoS Pathog. 2007 Oct 5;3(10):1374-9
references: 17922570
references: PLoS Med. 2009 May 19;6(5):e1000085
references: 19440354
references: N Engl J Med. 2005 Feb 17;352(7):686-91
references: 15716562
references: Proc Natl Acad Sci U S A. 2007 May 1;104(18):7588-93
references: 17416677
references: Ann Intern Med. 2012 Apr 3;156(7):512-24
references: 22371849
references: J R Soc Interface. 2008 Jun 6;5(23):631-9
references: 17916550
references: PLoS Med. 2010 May 18;7(5):e1000277
references: 20502525
references: Nature. 2006 Jul 27;442(7101):448-52
references: 16642006
references: Ann Hum Genet. 1972 Apr;35(4):485-90
references: 5073694
references: Parasitology. 1982 Oct;85 (Pt 2):411-26
references: 6755367
references: Science. 2012 Jun 22;336(6088):1506; author reply 1506
references: 22723396
references: Nature. 2005 Sep 8;437(7056):209-14
references: 16079797
references: Emerg Infect Dis. 2011 Feb;17(2):200-8
references: 21291589
references: J Virol. 2012 Mar;86(5):2706-14
references: 22205751
references: Proc Natl Acad Sci U S A. 2007 May 1;104(18):7582-7
references: 17416679
references: J R Soc Interface. 2008 May 6;5(22):545-53
references: 17725972
references: Science. 2012 Mar 23;335(6075):1463
references: 22362880
references: Clin Infect Dis. 2009 Jun 15;48(12):1639-46
references: 19435433
references: Science. 2001 Sep 7;293(5536):1840-2
references: 11546875
references: J Infect Dis. 2001 Feb 15;183(4):523-31
references: 11170976
references: Ecol Lett. 2007 Oct;10(10):876-88
references: 17845288
references: J Gen Virol. 2005 Oct;86(Pt 10):2831-2838
references: 16186239
references: Lancet Infect Dis. 2009 May;9(5):291-300
references: 19393959